-
Selloff in MedTech stocks 'seems overdone': Citi
-
Citi Reiterates Buy Rating on DexCom (DXCM), 'Favorable Court Ruling'
-
DexCom (DXCM) shares gain as Medicare to expand CGM coverage in April
-
Dexcom Announces Upcoming Conference Presentations
-
Citi Opens a Positive Catalyst Watch on DexCom, Negative on Nevro, Cuts Penumbra to Neutral
-
Citi opens a positive catalyst on DexCom (DXCM)
-
DexCom (DXCM) Catalyst Watch Closed at Citi
-
Dexcom Announces Upcoming Virtual Conference Presentations
-
Dexcom Announces Upcoming Virtual Conference Presentations
-
Notable Analyst Rating Changes 9/16: (INFO) (DAN) (GNMK) Upgraded; (FOXA) (C) (WFC) Downgraded
-
Notable Analyst Rating Changes 11/2: (MGM) (ABBV) (KEY) Upgraded; (JMEI) (SBRA) (ANET) Downgraded
-
Pre-Open Stock Movers 10/15: (FPRX) (BOFI) (DXCM) Higher; (IMPR) (MTW) (VRX) (STX) (GRMN) (HCA) (NFLX) Lower (more...)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
After-Hours Movers 01/14: GNV, DISK, ENER, CF, INTC Higher; COOL, ASTM, FALC, TRA Lower

